PPAR gamma activation protects the brain against microvascular dysfunction in sepsis

Area of Science:

• Neuroscience
• Immunology
• Pharmacology

Background:

• Sepsis involves systemic inflammation and can lead to organ dysfunction.
• Cerebral microcirculation alterations, including reduced capillary density and leukocyte dysfunction, are critical in sepsis.
• Mechanisms underlying sepsis-associated cerebral microcirculatory changes remain unclear.

Purpose of the Study:

• To investigate the protective effects of rosiglitazone, a peroxisome proliferator-activated receptor gamma (PPARγ) agonist, on cerebral microcirculation during sepsis.
• To examine rosiglitazone's impact on leukocyte-endothelial cell interactions and functional capillary density in the brain.

Main Methods:

• Utilized the cecal ligation and puncture (CLP) model to induce sepsis in animals.
• Administered rosiglitazone to assess its effects on cerebral microcirculation.
• Quantified functional capillary density and leukocyte rolling/adhesion in the brain.

Main Results:

• Rosiglitazone demonstrated significant anti-inflammatory effects on the cerebral microcirculation.
• Functional capillary density in the brain increased in CLP animals treated with rosiglitazone.
• Leukocyte rolling and adhesion were significantly decreased in rosiglitazone-treated animals.

Conclusions:

• PPARγ activation plays a role in regulating leukocyte-endothelium interactions and capillary density alterations in sepsis.
• Rosiglitazone treatment improved cerebral perfusion, suggesting PPARγ activation is protective against sepsis-induced cerebral microvascular dysfunction.